ÃÛ·èÖ±²¥

Academic, Government & Corporate Licensing

Databases & Solutions licensing

ÃÛ·èÖ±²¥'s database and software solutions provide user-friendly resources to conduct research quickly and effectively. Our bespoke purchasing models offer complete flexibility to fit your institution’s research needs. Continue reading to explore a variety of flexible licensing options available to you.

AdisInsight

  • AdisInsight

    Complete access to information about global drug development to identify opportunities, monitor competitors, and evaluate strengths and weaknesses allowing you to make more informed strategic decisions.

    Ideal for: All organizations involved in developing prescription pharmaceuticals or interested in the organizations that do

    		Content: With over 550,000 profiles in a single platform, AdisInsight provides users the latest information on drug development, clinical trials, adverse events, patent expiry, and biopharma deals.

    Rights: Subscription, No continuing access

    		Access: IP-range provides seamless access for all users in the organizations or Username/Password access for named individuals.

  • AdisInsight Start-up

    Complete access to information about global drug development at special commercial terms to help emerging biopharma organizations make informed strategic decisions.

    Ideal for: All biopharma organizations with series A, B, or C seed funding

    		Content: With over 550,000 profiles in a single platform, AdisInsight provides users the latest information on drug development, clinical trials, adverse events, patent expiry, and biopharma deals.

    Rights: Subscription, No continuing access

    		Access: Username/Password access for named individuals.

  • AdisInsight Safety

    Full access to a global biomedical reference database of validated Individual Case Safety Reports (ICSR) to improve the efficiency of ICSR literature monitoring.

    Ideal for: All organizations with marketing authorization for prescription pharmaceuticals

    		Content: Over 266,000 summaries of validated Individual Case Safety Reports for adverse events and special situations sourced from global journals regardless of publisher.

    Rights: Subscription, No continuing access

    		Access: IP-range provides seamless access for all users in the organizations or Username/Password access for named individuals.

  • AdisInsight Data Feed & API

    Full access to information included in AdisInsight authored summaries of drug development programs and/or clinical trials to support integration or big data analysis.

    Ideal for: All biopharma organizations pursuing data-driven drug research or aggregating information in an internal platform.

    		Content: Over 244,000 drug and trial profiles including phase of development linked to indication and location, drug properties and chemical synopsis, trial interventions, and trial outcomes.

    Rights: Subscription, No continuing access

    		Access: Username/Password access for named individuals.

  • AdisInsight Timelines

    Full access to key archive information included in AdisInsight authored summaries of drug development programs to assess trends and provide historical context.

    Ideal for: All organizations pursuing data-driven drug research or aggregating information in an internal platform.

    		Content: Over 48,000 drug profiles including drug name and synonyms, phase of development linked to indication and location, mechanism of action, and originator and licensee organizations.

    Rights: Continuing access

    		Access: Username/Password access for named individuals. 

SpringerMaterials

  • SpringerMaterials subscription

    Complete access to the entire database including the prestigious Landolt-Börnstein book series, MSI Eureka, and SpringerMaterials Interactive

    Ideal for: All research institutions aiming to increase research productivity in materials science

    		Content: With over 290,000 materials and 3,000+ properties in a single platform, SpringerMaterials provides consolidated, multisource data from all major topics in materials science, chemistry, physics, and engineering

    Rights: No archival rights

    		Access: Seamless and unlimited access to the entire database during the contract term via IP-Range or seat based model

  • Archive

    SpringerMaterials is pleased to offer two archival data sets: the complete Landolt-Börnstein book series - the most prestigious materials science book collection in the world, and the MSI Eureka database - a comprehensive collection of phase diagrams

    Ideal for: Institutions looking to lower ongoing costs by adding valuable materials science data to their library

    		Content: Ownership of archived content up to, but not including the current copyright year

    Rights: Continuing access rights to archival content

    		Access: Access only to archival content of years purchased. No access to remaining parts of the platform

    Special note: Each archival purchase entitles the institution to a special discounted subscription price for access to the entire SpringerMaterials platform. Contact your local ÃÛ·èÖ±²¥ licensing representative today for your discounted subscription offer.

SpringerProtocols

Terms and conditions apply

ÃÛ·èÖ±²¥ strives to serve the entire research community by offering flexible licensing and subscriptions options across all regions and markets. There may be instances where depending on the region and/or market, some restrictions might apply for some of the above mentioned product offerings. For more details, please contact your local representative.